Pierre Vermeulen

Title: Pierre Vermeulen: Innovator in Fibrin-Based Technologies

Introduction

Pierre Vermeulen is a notable inventor based in Lillois, Belgium. He has made significant contributions to the field of medical technology, particularly through his innovative work involving fibrin-based materials. His expertise and creativity have led to the development of a unique patent that addresses important needs in medical applications.

Latest Patents

One of Pierre Vermeulen's key patents is titled "Element provided with a fibrin layer, preparation and use thereof." This invention involves an element that features a layer based on fibrin or fibrinogen-containing material. The element comprises a hydrophobic support with a porous part, which has a thickness ranging from 0.1 to 5 mm. The pores within this support extend across its thickness and have a node spacing of 5 to 100 micrometers. One face of the porous part is treated with a compound based on fibrin and/or a fibrinogen-containing material. Additionally, a fibrin-based layer covers the treated surface of the support, ensuring that the fibrin layer is substantially uniform and homogeneous. Importantly, both the fibrin layer and the face of the support in contact with it are substantially free of fibrinogen. This innovative approach has the potential to enhance various medical applications.

Career Highlights

Pierre Vermeulen is associated with Baxter International Inc., a leading company in the healthcare sector. His work at Baxter has allowed him to focus on developing advanced medical technologies that improve patient outcomes. With a total of 1 patent to his name, Vermeulen has established himself as a valuable contributor to the field.

Collaborations

Throughout his career, Pierre has collaborated with talented professionals, including Yves A Delmotte and Nathalie Belot. These collaborations have fostered an environment of innovation and creativity, leading to advancements in medical technology.

Conclusion

Pierre Vermeulen's contributions to fibrin-based technologies exemplify the impact of innovative thinking in the medical field. His patent and work at Baxter International Inc. highlight the importance of research and development in creating solutions that benefit healthcare.